Poly Medicure Surges 4.32% to ₹2,068.80 After Global Expansion Move

New Delhi, September 25, 2025 – Shares of Poly Medicure Ltd (NSE: POLYMED, BSE: 531768) increased by 4.32% in the morning trading session on Thursday. This shift gained momentum in anticipation of the diversification of international business and the recent grant of employee stock options.

Founded in 1995 and publicly traded since 2011, Poly Medicure is one of India’s leading manufacturers of medical devices and disposables. Its portfolio consists of products related to infusion therapy, anesthesia, surgery and dialysis, and has a wide global reach.

Trading Snapshot

On 25 September, Poly Medicure closed at ₹2,030.60, up ₹47.50 (2.40%) from its last close of ₹1,983.10. It opened at ₹1,994.90 and rose to an intraday peak of ₹2,080.00 before closing slightly lower. This follows a 1.5% rise on September 24, when the stock closed at ₹1,983.10 with 1.60 lakh shares traded, giving a total traded value of ₹32.69 crore. The company’s market capitalization stands at ₹20,938.96 crore, and its stock has a P/E ratio of 57.16, while being a constituent of the Nifty Smallcap 250 index.

Growth Drivers

The recent momentum was driven by news that a Poly Medicure subsidiary will purchase Medistream SA of Switzerland, including Medistream’s subsidiaries in Italy, the US, and Mexico. This acquisition grants complete ownership of the Citieffe Group, further expanding Poly Medicure’s international presence. The company also allocated 33,775 shares from its ESOP 2020 plan, increasing its paid-up capital to ₹50.68 crore.

Outlook

Through purposeful purchases and organic growth in funding, Poly Medicure is expected to maintain its development momentum. This shift positions the company well in international markets, while also enhancing shareholder value in the medium term.

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations